Status:
COMPLETED
Effects of a Supplement on Acute Respiratory Infections
Lead Sponsor:
Omnilife Manufactura, SA de CV
Collaborating Sponsors:
University of Guadalajara
Conditions:
Respiratory Tract Infection
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether the consumption of a nutritional supplement with micronutrients and herbal extracts has an effect on the incidence of acute respiratory infections in ...
Detailed Description
We conducted a randomized, parallel, double-blind, placebo-controlled, 90-day clinical trial from January to April, 2012. All staff who worked at the Omnilife's Entrepreneur Support Department (CREO b...
Eligibility Criteria
Inclusion
- Healthy adult subjects (without active respiratory infections, or without diseases that compromise immune system)
- Who presented no abnormalities in their laboratory tests (active infections, immunosuppression, renal or hepatic impairment)
- Who did not take drugs that affect the immune system (anti-inflammatory drugs, antibiotics, steroids).
Exclusion
- Subjects with active acute respiratory infections.
- Subjects with chronic respiratory disease requiring treatment other than bronchodilators at the time of assessment.
- Subjects with diseases affecting the immune system (autoimmune illness, diabetes, etc.)
- Pregnant women or currently nursing.
- Subjects with cardiovascular disorders (uncontrolled hypertension) or neurological disorders (epilepsy).
- Subjects with allergies to any components of the products.
- Subjects with low treatment adherence (less than 80%).
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT02210156
Start Date
January 1 2012
End Date
April 1 2012
Last Update
August 7 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Omnilife
Guadalajara, Jalisco, Mexico, 44500